Skip to main content
SpringerLink
Log in

Direct, DNA pol-γ-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics

  • Reviews
  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Nucleoside reverse transcriptase inhibitor (NRTI)-induced cardiomyopathy has been suggested to reflect mitochondrial targets of drug toxicity. The prevailing hypothesis is that, through structural mimicry, the NRTIs are mistaken as substrates for DNA polymerase and incorporated into replicating DNA, where they cause truncation of the elongating strand. Although there exist five forms of nuclear DNA polymerase, mitochondria possess solely DNA polymerase-γ (pol-γ), which is a preferred target for most NRTIs. Consequently, mitochondria are particularly susceptible to inhibition of DNA replication by the NRTIs, which is consistent with the phenotype of mitochondrial depletion and metabolic failure in affected patients. However, the DNA pol-γ hypothesis by itself fails to explain the entire array of metabolic deficiencies associated with NRTI-induced disorders. In this article, we review the published literature regarding the direct effects of NRTIs on various mitochondrial targets and suggest the possibility that the initiating event in NRTI-induced cardiomyopathy is a direct mitochondrial toxicity rather than inhibition of mitochondrial DNA pol-γ. The goal of this review is to encourage a discussion of the cause of NRTI-induced mitochondrial cardiomyopathy to include a fresh consideration of all possible targets and integrating pathways that are involved in establishing mitochondrial bioenergetic fidelity and metabolic capacity in the affected myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yarchoan, R., Klecker, R., Weinhold, K., Markham, P., Lyerly, H., Durack, D., et al. (1986). Administration of 3′azido-3′deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1:575–580.

    Article  PubMed  CAS  Google Scholar 

  2. Helbert, M., Fletcher, T., Peddle, B., Harris, J.R.W., and Pinching, A.J. (1988). Zidovudine-associated myopathy. Lancet 2:689–690.

    Article  PubMed  CAS  Google Scholar 

  3. Bessen, L., Greene, J., Louie, E., Seitzman, P., and Weinberg, H. (1988). Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N. Engl. J. Med. 318:708.

    PubMed  CAS  Google Scholar 

  4. Brinkman, K., ter Hofstede, H.J., Burger, D., Smeitink, J., and Koopmans, P. (1998). Adverse effects of reverse transcriptase inhibitions: mitochondrial toxicity as common pathway. AIDS 12:1735–1744.

    Article  PubMed  CAS  Google Scholar 

  5. Kakuda, T.N. (2000). Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin. Ther. 22:685–708.

    Article  PubMed  CAS  Google Scholar 

  6. Lewis, W. and Dalakas, M.C. (1995), Mitochondrial toxicity of antiviral drugs. Nat. Med. 1:417–422.

    Article  PubMed  CAS  Google Scholar 

  7. Lewis, W., Copeland, W.C., and Day, B.J. (2001). Mitochondrial DNA depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors. Lab. Invest. 81:777–790.

    PubMed  CAS  Google Scholar 

  8. Barazzoni, R., Short, K.R., and Nair, K.S. (2000). Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J. Biol. Chem. 275:3343–3347.

    Article  PubMed  CAS  Google Scholar 

  9. Sogl, B., Gellissen, G., and Wiesner, R.J. (2000). Biogenesis of giant mitochondria during insect flight muscle development in the locust, Locusta migratoria: transcription, translation and copy number of mitochondrial DNA. Eur. J. Biochem. 267:11–17.

    Article  PubMed  CAS  Google Scholar 

  10. Dalakas, M.C., Illa, I., Pezeshkpour, G.H., Laukaitis, J.P., Cohen, B., and Griffin, J.L. (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322:1098–1105.

    Article  PubMed  CAS  Google Scholar 

  11. Tang, Y., Schon, E.A., Wilichowski, E., Vasquez-Memije, M.E., Davidson, E., and King, M.P. (2000). Rearrangements of human mitochondrial DNA (mtDNA): new insights into the regulation of mtDNA copy number and gene expression. Mol. Biol. Cell. 11:1471–1485.

    PubMed  CAS  Google Scholar 

  12. Pereira, L.F., Oliveira, M.B.M., and Carnieri, E.G.S. (1998). Mitochondrial sensitivity to AZT. Cell Biochem. Funct. 16:173–181.

    Article  PubMed  CAS  Google Scholar 

  13. Lamperth, L., Dalakas, M.C., Dagani, F., Anderson, J., and Ferrari, R. (1991). Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest. 65:742–751.

    PubMed  CAS  Google Scholar 

  14. Szabados, E., Fischer, G.M., Toth, K., Csete, B., Nemeti, B., Trombitas, K., et al. (1999). Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic. Biol. Med. 26:309–317.

    Article  PubMed  CAS  Google Scholar 

  15. Cazzalini, O., Lazze, M.C., Lamele, L., Stivala, L.A., Bianchi, L., Vaghi, P., et al. (2001). Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes. Biochem. Pharmacol. 62:893–902.

    Article  PubMed  CAS  Google Scholar 

  16. Modica-Napolitano, J.S. (1993). AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem. Biophys. Res. Commun. 194:170–177.

    Article  PubMed  CAS  Google Scholar 

  17. Benbrik, E., Chariot, P., Bonavaud, S., Ammi-Said, M., Frisdal, E., Rey, C., et al. (1997). Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI), and zalcitabine (ddC) on cultured human muscle cells. J. Neurol. Sci. 149:19–25.

    Article  PubMed  CAS  Google Scholar 

  18. Pan-Zhou, Z.-R., Cui, L., Zhou, X-J., Sommadossi, J.-P., and Darley-Usmar, V.M. (2000). Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrob. Agents Chemother. 44: 496–503.

    Article  PubMed  CAS  Google Scholar 

  19. Atlante, A. and Passarella, S. (1998). AZT side effect on mitochondria does not depend on either inhibition of electron flow or mitochondrial uncoupling. Int. J. Mol. Med. 1:601–603.

    PubMed  CAS  Google Scholar 

  20. Gerschenson, M., Erhart, S.W., Paik, C.Y., Claire, M.C.S., Nagashima, K., Skopets, B., et al. (2000). Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido'-3′-deoxythymidine. AIDS Res. Hum. Retroviruses 16:635–644.

    Article  PubMed  CAS  Google Scholar 

  21. Hobbs, G.A., Keilbaugh, S.A., Reif, P.M., and Simpson, M.V. (1995). Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation. Biochem. Pharmacol. 50:381–390.

    Article  PubMed  CAS  Google Scholar 

  22. Keilbaugh, S.A., Hobbs, G.A., and Simpson, M.V. (1997). Effect of 2′,3′-deoxycytidine on oxidative phosphorylation in the PC12 cell, a neuronal model. Biochem. Pharmacol. 53:1485–1492.

    Article  PubMed  CAS  Google Scholar 

  23. Valenti, D., Atlante, A., Barile, M., and Passarella, S. (2002). Inhibition of phosphate transport in rat heart mitochondria by 3′-azido-3′-deoxythymidine due to stimulation of superoxide anion mitochondrial production. Biochem. Pharmacol. 64:201–206.

    Article  PubMed  CAS  Google Scholar 

  24. Genova, M.L., Ventura, B., Giuliano, G., Bovina, C., Formiggini, G., Castelli, G.P., et al. (2001). The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinoe but presumably ironsulfur cluster N2. FEBS Lett. 505:364–368.

    Article  PubMed  CAS  Google Scholar 

  25. Sutliff, R.L., Dikalov, S., Weiss, D., Parker, J., Raidel, S., Racine, A.K., et al. (2002). Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide. Am. J. Physiol. Heart Circ. Physiol. 283:H2363-H2370.

    PubMed  CAS  Google Scholar 

  26. Collier, A.C., Helliwell, R.J.A., Keelan, J.A., Paxton, J.W., Mitchell, M.D., and Tingle, M.D. (2003). 3′-A zido-3′-deoxythymidine (AZT) induces apoptosis and alters metabolic activity in human placenta. Toxicol. Appl. Pharmacol. 192:164–173.

    Article  PubMed  CAS  Google Scholar 

  27. Elimadi, A., Morin, D., Albengres, E., Chauyet-Monges, A.-M., Allain, V., Crevat, A., et al. (1997). Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation. Br. J. Pharmacol. 121:1295–1300.

    Article  PubMed  CAS  Google Scholar 

  28. Sales, S.D., Hoggard, P.G., Sunderland, D., Khoo, S., Hart, C.A., and Back, D.J. (2001). Zidovudine phosphorylation and mitochondrial toxicity in vitro. Toxicol. Appl. Pharmacol. 177:54–58.

    Article  PubMed  CAS  Google Scholar 

  29. Wada, S., Tsuda, M., Sekine, T., Cha, S.H., Kimura, M., Kanai, Y., et al. (2000). Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J. Pharmacol. Exp. Ther. 294:844–849.

    PubMed  CAS  Google Scholar 

  30. Masini, A., Scotti, C., Caligaro, A., Cazzalini, O., Stivala, L.A., Bianchi, L., et al. (1999). Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage. J. Neurol. Sci. 166:131–140.

    Article  PubMed  CAS  Google Scholar 

  31. Chen, Q., Vazquez, E.J., Moghaddas, S., Hoppel, C.L., and Lesnefsky, E.J. (2003). Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278:36027–36031.

    Article  PubMed  CAS  Google Scholar 

  32. Herzberg, N.H., Zorn, I., Zwart, R., Portegies, P., and Bolhuis, P.A. (1992). Major growth reduction and minor decrese in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine. Muscle Nerve 15:706–710.

    Article  PubMed  CAS  Google Scholar 

  33. Freyssenet, D., DiCarlo, M., Escobar, P., Grey, J., Schneider, J., and Hood, D.A. (1999). Zidovudine (AZT) induced alterations in mitochondrial biogenesis in rat striated muscles. Can. J. Physiol. Pharmacol. 77:29–35.

    Article  PubMed  CAS  Google Scholar 

  34. McCurdy, D.T. and Kennedy, J.M. (1996). Skeletal muscle mitochondria from AZT-treated rats have a diminished response to chronic electrical stimulation. J. Appl. Physiol. 81:326–334.

    PubMed  CAS  Google Scholar 

  35. McCurdy, D.T. and Kennedy, J.M. (1998). AZT decreases rat myocardial cytochrome oxidase activity and increases b-myosin heavy chain content. J. Mol. Cell. Cardiol. 30: 1979–1989.

    Article  PubMed  CAS  Google Scholar 

  36. Sommadossi, J.P., Carlisle, R., and Zhou, Z. (1989). Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol. Pharmacol. 36:9–14.

    PubMed  CAS  Google Scholar 

  37. Weidner, D.A. and Sommadossi, J.P. (1990). 3′-Azido-3′-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells. Mol. Pharmacol. 38:797–804.

    PubMed  CAS  Google Scholar 

  38. Agarwal, R.P. and Olivero, O.A. (1997). Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3′-azido-2′,3′-deoxythymidine. Mutat. Res. 390:223–231.

    PubMed  CAS  Google Scholar 

  39. Martin, J.L., Brown, C.E., Matthews-Davis, N., and Reardon, J.E. (1994). Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38:2743–2749.

    PubMed  CAS  Google Scholar 

  40. Cheng, Y.C., Gao, W.Y., Chen, C.H., Vazquez-Padua, M., and Starnes, M.C. (1990). DNA polymerases versus HIV reverse transcriptase in AIDS therapy. Ann. NY Acad. Sci. 616:217–223.

    Article  PubMed  CAS  Google Scholar 

  41. Yamaguchi, T., Katoh, I., and Kurata, S.-I. (2002). Azidothymidine causes functional and structural destruction of mitochondria, glutathione deficiency and HIV-1 promoter sensitization. Eur. J. Biochem. 269:2782–2788.

    Article  PubMed  CAS  Google Scholar 

  42. Barile, M., Valenti, D., Passarella, S., and Quagliariello, E. (1997). 3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator. Biochem. Pharmacol. 53:913–920.

    Article  PubMed  CAS  Google Scholar 

  43. Barile, M., Valenti, D., Hobbs, G.A., Abruzzese, M.F., Keilbaugh, S.A., Quadgliariello, E., et al. (1994). Mechanisms of toxicity of 3′-azido-3′-deoxythymidine: its interaction with adenylate kinase. Biochem. Pharmacol. 48:1405–1412.

    Article  PubMed  CAS  Google Scholar 

  44. Valenti, D., Barile, M., Quagliariello, E., and Passarella, S. (1999). Inhibition of nucleoside diphosphate kinase in rat liver mitochondria by added 3′-azido-3′-deoxythymidine. FEBS Lett. 444:291–295.

    Article  PubMed  CAS  Google Scholar 

  45. Bourdais, J., Biondi, R., Sarfati, S., Guerreiro, C., Lascu, I., Janin, J. et al. (1996). Cellular phosphorylation of anti-HIV nucleosides. J. Biol. Chem. 271:7887–7890.

    Article  PubMed  CAS  Google Scholar 

  46. Moraes, C.T. (2001). What regulates mitochondrial DNA copy number in animal cells?. Trends Genet. 17:199–205.

    Article  PubMed  CAS  Google Scholar 

  47. D’Amati, G., and Lewis, W. (1994). Zidovudine causes early increses in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells. Lab. Invest. 71:879–884.

    PubMed  CAS  Google Scholar 

  48. Gerschenson, M., Nguyen, V.T., Claire, M.C.S., Harbaugh, S.W., Harbaugh, J.W., Proia, L.A., et al. (2001). Chronic stavudine exposure induces hepatic mitochondrial toxicity in adult Erythocebus patas monkeys. J. Hum. Virol. 4: 335–342.

    PubMed  CAS  Google Scholar 

  49. Georges, B., Galland, S., Rigault, C., Borgne, F.L., and Demarquoy, J. (2003). Beneficial effects of 1-carnitine in myoblastic C2C12 cells: interaction with zidovudine. Biochem. Pharmacol. 65:1483–1488.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Toxicology Graduate Program, University of Minnesota School of Medicine, 262, 1035 University Drive, 55812-3031, Duluth, MN

    Kaleb C. Lund & Kendall B. Wallace

Authors
  1. Kaleb C. Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kendall B. Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kaleb C. Lund.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lund, K.C., Wallace, K.B. Direct, DNA pol-γ-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics. Cardiovasc Toxicol 4, 217–228 (2004). https://doi.org/10.1385/CT:4:3:217

Download citation

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/CT:4:3:217

Key Words

Search

Navigation